Osaic Holdings’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17K Buy
10,452
+4,975
+91% +$8.49K ﹤0.01% 5952
2025
Q4
$9.75K Buy
+5,477
New +$11.4K ﹤0.01% 6364
2024
Q2
Sell
-3,000
Closed -$7.11K 7548
2024
Q1
$7.11K Hold
3,000
﹤0.01% 5931
2023
Q4
$8.43K Buy
+3,000
New +$8.64K ﹤0.01% 5917
2022
Q1
Sell
-667
Closed -$2K 7414
2021
Q4
$2K Hold
667
﹤0.01% 7035
2021
Q3
$3K Hold
667
﹤0.01% 6753
2021
Q2
$3K Hold
667
﹤0.01% 6609
2021
Q1
$7K Sell
667
-133
-17% -$1.58K ﹤0.01% 6033
2020
Q4
$4K Buy
800
+133
+20% +$704 ﹤0.01% 5864
2020
Q3
$4K Buy
667
+134
+25% +$850 ﹤0.01% 5650
2020
Q2
$4K Buy
+533
New +$5.41K ﹤0.01% 5576

Other funds holding NSPR

Osaic Holdings's NSPR Position: Q1 2026 in Review

Osaic Holdings increased its InspireMD (NSPR) stake by 91% in Q1 2026, buying an estimated $8.49K and bringing the position to 10,452 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #5952.

Osaic Holdings first reported a position in NSPR in Q2 2020 and has held it in 11 quarters since. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Osaic Holdings held 10,452 shares of InspireMD worth $17K as of Q1 2026.
  • Osaic Holdings bought 4,975 InspireMD shares in Q1 2026, an estimated $8.49K.
  • InspireMD made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5952 holding.
  • Osaic Holdings first reported a position in InspireMD in Q2 2020 and has held it in 11 quarters since.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.